Eterna Therapeutics Inc. (ERNA)
NASDAQ · Healthcare
Eterna Therapeutics Inc. EPS 2010–2024
Eterna Therapeutics Inc. annual/quarterly eps history and growth rate from 2020 to 2024. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Eterna Therapeutics Inc. eps for the quarter ending September 30, 2024 was $73.70, a 7055.34% increase year-over-year.
- Eterna Therapeutics Inc. annual eps for 2024 was $48.96, a 1100.00% increase from 2023.
- Eterna Therapeutics Inc. annual eps for 2023 was $4.08, a 49.38% decrease from 2022.
- Eterna Therapeutics Inc. annual eps for 2022 was $8.06, a 1865.85% increase from 2020.
- Eterna Therapeutics Inc. annual eps for 2020 was $0.41.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Eterna Therapeutics Inc. EPS — FAQ
Eterna Therapeutics Inc. (ERNA) eps over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Eterna Therapeutics Inc.'s eps?
Eterna Therapeutics Inc. (ERNA) reported eps of $-48.96 for fiscal 2024.
Where can I see ERNA's eps history?
The chart and table above show Eterna Therapeutics Inc.'s eps by year and by quarter, including the growth rate.